Hints and tips:
Related Special Reports
...The money pouring into ADCs is a reminder of just how important oncology is to the pharmaceutical sector, even as obesity steals the limelight....
...[Enlarge] Further reading:— Alert: Alphaville LLC issues new research report on Duchy of Cornwall (FTAV)— Greenland: Alphaville put on its sellside hat for the deal of the century (FTAV)— Alphaville LLC...
...Japan’s Takeda Pharmaceuticals has reached an up to $2.1bn deal to develop an Alzheimer’s vaccine made by Swiss start-up AC Immune, as pharmaceutical companies race to invest in potentially lucrative new...
From Lawrence A Rand, Managing Director, 55 Pine Street LLC, Visiting Professor of Economics, Brown University, Weston, MA, US
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...Japan’s Takeda Pharmaceuticals has reached a deal worth up to $2.2bn to develop an Alzheimer’s vaccine made by Swiss start-up AC Immune, as drug companies race to invest in potentially lucrative new treatments...
...Ireland’s economy has officially entered recession after contracting by 1.9 per cent in the third quarter, pushed lower by a drop in pharmaceutical exports....
...Eli Lilly last week announced a deal to buy a Wisconsin-based production facility for filling its injectable pens from Nexus Pharmaceuticals....
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...This is an audio transcript of the Behind the Money podcast episode: ‘Ozempic’s unconventional origins’ Michela Tindera It’s November, and the FT’s global pharmaceutical editor Hannah Kuchler is in Copenhagen...
...The early-stage plans are the latest effort by a pharmaceutical company to circumvent industry middlemen and sell drugs directly to US patients....
...GLP-1s now underpin a weight loss drug, Wegovy, developed by pharmaceutical group Novo Nordisk....
...The pharmaceutical industry has no shortage of funds or motivation when it comes to improving drug discovery success rates using AI....
...communique issued on Wednesday, the party’s deeply feared internal watchdog, the Central Commission for Discipline Inspection, said it would prioritise investigation into the finance, agricultural and pharmaceutical...
...The announcement comes after the pharmaceutical group requested in March that the European Union marketing authorisation for Vaxzevria be withdrawn, a request that was granted on Tuesday....
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...Isomorphic Labs has partnerships with pharmaceutical companies Eli Lilly and Novartis....
...This has led to western pharmaceutical regulators struggling to enforce oversight of Chinese manufacturers....
...The partnership strengthens Sanofi, one of the world’s largest vaccine makers by sales, in the post-pandemic Covid jab market, where pharmaceutical groups are increasingly focused on combined shots against...
...Emblaveo, marketed in Europe by US pharmaceutical company Pfizer, combines two existing medicines to tackle so-called Gram-negative bacteria that are among the leading drug-resistance threats....
...Cheaper valuations have finally drawn cash-rich pharmaceutical makers back to biotechs. Their aim, as always, is to replenish their drug pipelines affordably. Relief is sorely needed....
...But pharmaceutical companies can file several patents for single drugs at different times, delaying the entry of generic medicines....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
International Edition